Looking at Verizon's Q4 earnings, analyst Jim Patterson described the optimistic take as a sign that management can navigate through consumer and business headwinds.

Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.

Democrats are sounding the alarm over President Trump’s move to freeze funding approved in two of President Biden’s signature ...